The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies

Spencer AJ., Morris S., Ulaszewska M., Powers C., Kailath R., Bissett C., Truby A., Thakur N., Newman J., Allen ER., Rudiansyah I., Liu C., Dejnirattisai W., Mongkolsapaya J., Davies H., Donnellan FR., Pulido D., Peacock TP., Barclay WS., Bright H., Ren K., Screaton G., McTamney P., Bailey D., Gilbert SC., Lambe T.

DOI

10.1016/j.ebiom.2022.103902

Type

Journal article

Journal

eBioMedicine

Publisher

Elsevier BV

Publication Date

03/2022

Volume

77

Pages

103902 - 103902

Permalink Original publication